Seagen to Present at the J.P. Morgan Healthcare Conference

BOTHELL, Wash.--(BUSINESS WIRE)-- Seagen Inc. (Nasdaq: SGEN) today announced that management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 3:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from the investor section of Seagen’s website at investor.seagen.com.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005153/en/

For Investors
Peggy Pinkston
Senior Vice President, Investor Relations
(425) 527-4160
[email protected]

For Media
David Caouette
Vice President, Corporate Communications
(310) 430-3476
[email protected]

Source: Seagen Inc.

You May Also Be Interested In

• Posiflex Unveils AI-Powered SCO Series Kiosk to Accelerate the Future of Self-Service Retail
• Olympia Financial Group Inc. Announces October Dividend
• XRP Treasury Company Evernorth Nears Nasdaq Debut With 473 Million XRP: BTCPressWire on the Public-Market Crypto Shift